To the question of the development of arterial hypertension in urban residents with obesity

Main Article Content

T.I. Yefimenko
E.V. Misyura


Background. The relevance of the study is due to the need to optimize the prevention of arterial hypertension (AH) among the urban population of Ukraine, primarily those with obesity. The purpose was to detail the features of AH development in obese urban residents, and to develop a method for predicting AH in this category of the population. Materials and methods. A total of 1,094 residents of the city of Kharkiv who had not been treated for obesity and AH were examined. Body mass index, waist circumference, blood pressure were evaluated. Bioimpedance analysis was used to study body composition, immunoassay — serum levels of insulin, leptin, renin, aldosterone and clusterin. Features of central hemodynamics were assessed by the method of integral body rheography: stroke volume (ml), cardiac output (L/min), stroke volume index (ml/m2), cardiac index (L/min/m2) were determined. Results. It was found that middle-aged urban residents with obesity require intensification of preventive work in terms of AH development. In men, it should be started even before the age of 40. Development of concomitant pathology of AH and obesity in middle-aged people is due to the presence of insulin resistance, which is accompanied by changes in the circulating levels of insulin, leptin, aldosterone, in the stroke volume index and total peripheral vascular resistance, the occurrence of low-grade systemic inflammation in the body. Patients with obesity and AH differ from those with AH without obesity in terms of the level of volemia, the severity of changes in hemodynamics caused by the functioning of the heart, total peripheral vascular resistance, the degree of chan­ges in the renin-aldosterone system, and the intensity of low-grade systemic inflammation. The results of the work made it possible to assert that one of the factors that primarily determine the development and progression of obesity in this category of the population is insulin resistance. Integral body rheography, a method for detec­ting changes in the stroke volume index, is an informative marker for the development and progression of AH. The presence of concomitant pathology of AH and obesity is characterized by changes in the levels of leptin and clusterin compared to the patients with obesity without hypertension, which should also be taken into account when developing therapeutic approaches. Conclusions. The approaches to the prognostic classification (created using the discriminant analysis program) of middle-aged urban residents — representatives of the Ukrainian population, identified in the process of work, can become the basis for optimizing the algorithms for the formation of risk groups for the development of obesity and AH.

Article Details

How to Cite
Yefimenko, T., and E. Misyura. “To the Question of the Development of Arterial Hypertension in Urban Residents With Obesity”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 16, no. 8, Apr. 2021, pp. 698-07, doi:10.22141/2224-0721.16.8.2020.222892.
Original Researches


Shariq OA, McKenzie TJ. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Gland Surg. 2020 Feb;9(1):80-93. doi:10.21037/gs.2019.12.03.

Jiang SZ, Lu W, Zong XF, Ruan HY, Liu Y. Obesity and hypertension. Exp Ther Med. 2016 Oct;12(4):2395-2399. doi:10.3892/etm.2016.3667.

Schütten MT, Houben AJ, de Leeuw PW, Stehouwer CD. The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension. Physiology (Bethesda). 2017 May;32(3):197-209. doi:10.1152/physiol.00037.2016.

Cabandugama PK, Gardner MJ, Sowers JR. The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome. Med Clin North Am. 2017 Jan;101(1):129-137. doi:10.1016/j.mcna.2016.08.009.

Koval SM, Yushko KO, Snihurska IO, et al. Relations of angiotensin-(1-7) with hemodynamic and cardiac structural and functional parameters in patients with hypertension and type 2 diabetes. Arterial Hypertension (Poland). 2019;23(3):183-189. doi:10.5603/AH.a2019.0012.

Cohen JB. Hypertension in Obesity and the Impact of Weight Loss. Curr Cardiol Rep. 2017 Aug 24;19(10):98. doi:10.1007/s11886-017-0912-4.

Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006 Feb 14;113(6):898-918. doi:10.1161/CIRCULATIONAHA.106.171016.

Fantin F, Giani A, Zoico E, Rossi AP, Mazzali G, Zamboni M. Weight Loss and Hypertension in Obese Subjects. Nutrients. 2019 Jul 21;11(7):1667. doi:10.3390/nu11071667.

Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des. 2004;10(29):3621-3637. doi:10.2174/1381612043382855.

Kravchun NA, Polozova LG, Popova SS, Dorosh YeG. Hypercorticoidism and obesity. Mìžnarodnij endokrinologìčnij žurnal. 2014;(58):81-84. doi:10.22141/2224-0721.2.58.2014.76478. (in Russian).

Tsioufis C, Stougiannos P, Kakkavas A, et al. Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension. Am J Cardiol. 2005 Jul 15;96(2):252-256. doi:10.1016/j.amjcard.2005.03.054.

Watanabe T, Yasunari K, Nakamura M, Maeda K. Carotid artery intima-media thickness and reactive oxygen species formation by monocytes in hypertensive patients. J Hum Hypertens. 2006 May;20(5):336-340. doi:10.1038/sj.jhh.1001990.

Navarro-González JF, Mora C, Muros M, García J, Donate J, Cazaña V. Relationship between inflammation and microalbuminuria in prehypertension. J Hum Hypertens. 2013 Feb;27(2):119-25. doi:10.1038/jhh.2011.118.

Misiura KV, Kravchun PP. Clusterin as an indicator of systemic inflammation in individuals with different body mass. Bulletin of problems biology and medicine. 2017;(137):174-179. (in Ukrainian).

Murata C, Ramírez AB, Ramírez G, Cruz A, Morales JL, Lugo-Reyes SO. Discriminant analysis to predict the clinical diagnosis of primary immunodeficiencies: a preliminary report. Rev Alerg Mex. 2015 Apr-Jun;62(2):125-133. (in Spanish).

Germino FW. The management and treatment of hypertension. Clin Cornerstone. 2009;9 Suppl 3:S27-33. doi:10.1016/s1098-3597(09)60016-8.

Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension. 2000 Jun;35(6):1270-1277. doi:10.1161/01.hyp.35.6.1270.

Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012 Apr;19(2):81-87. doi:10.1097/MED.0b013e3283514e13.

Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 2017 Jul 11;23(7):804-814. doi:10.1038/nm.4350.